Comet M-A, Laguzzi R, Hamon M, Sévoz-Couche C
Inserm U.288, Faculté de Médecine Pitié-Salpêtrière, 91 Boulevard de l'Hôpital, 75634 Paris Cedex 13, France.
Cardiovasc Res. 2005 Mar 1;65(4):930-9. doi: 10.1016/j.cardiores.2004.11.012.
Previous data showed that in the nucleus tractus solitarius (NTS), 5-HT(3) receptors are critically involved in the inhibition of cardiac baroreceptor reflex response occurring during the defense reaction. Since stimulation of NTS NK(1) receptors has been found to inhibit the baroreflex bradycardia, we examined in this study whether this reflex response is inhibited during the defense reaction via an interaction between NK(1) and 5-HT(3) receptors.
For this purpose, we analyzed in urethane-anaesthetized rats the effects of intra-NTS GR205171, a selective NK(1) receptor antagonist, on the baroreflex bradycardia inhibition observed either during the defense reaction triggered by electrical stimulation of the dorsal periaqueductal grey matter (dPAG) or after NTS 5-HT(3) receptor activation.
Intra-NTS GR205171, reversed, in dose-dependent manner, the inhibitory effect of dPAG stimulation on baroreflex bradycardia. This reversion was of 49% when both sinus carotid and aortic baroreceptors were stimulated by phenylephrine, and of 84% when aortic depressor nerve was stimulated. Similarly, intra-NTS GR205171 reversed partially or almost totally the inhibitory effect of local microinjections of phenylbiguanide, a 5-HT(3) receptor agonist, on baroreflex bradycardia induced either by phenylephrine administration or aortic nerve stimulation, respectively.
These results strongly suggest that NK(1) receptors contribute downstream to the 5-HT(3) receptor-mediated inhibition of the aortic but not carotid cardiac baroreflex response occurring during the defense reaction, therefore implying that baroreceptor afferent inputs may be differentially modulated depending on their origin. This differentiation may be useful for a better understanding of baroreflex dysfunction in disease-induced conditions.
先前的数据表明,在孤束核(NTS)中,5-羟色胺(3)受体在防御反应期间对心脏压力感受器反射反应的抑制中起关键作用。由于已发现刺激NTS NK(1)受体会抑制压力感受性反射性心动过缓,因此我们在本研究中检查了这种反射反应在防御反应期间是否通过NK(1)和5-羟色胺(3)受体之间的相互作用而受到抑制。
为此,我们在氨基甲酸乙酯麻醉的大鼠中分析了NTS内选择性NK(1)受体拮抗剂GR205171对在由电刺激导水管周围灰质背侧(dPAG)引发的防御反应期间或NTS 5-羟色胺(3)受体激活后观察到的压力感受性反射性心动过缓抑制的影响。
NTS内注射GR205171以剂量依赖性方式逆转了dPAG刺激对压力感受性反射性心动过缓的抑制作用。当用去氧肾上腺素刺激颈总动脉和主动脉压力感受器时,这种逆转率为49%,而当刺激主动脉减压神经时,逆转率为84%。同样,NTS内注射GR205171分别部分或几乎完全逆转了局部微量注射5-羟色胺(3)受体激动剂苯乙双胍对由去氧肾上腺素给药或主动脉神经刺激诱导的压力感受性反射性心动过缓的抑制作用。
这些结果强烈表明,NK(1)受体在下游促成5-羟色胺(3)受体介导的防御反应期间发生的主动脉而非颈动脉心脏压力感受器反射反应的抑制,因此意味着压力感受器传入输入可能根据其起源受到不同的调节。这种差异可能有助于更好地理解疾病诱发条件下的压力感受性反射功能障碍。